HCMT
CLSD

Highland Capital Management (Tennessee)’s Clearside Biomedical CLSD Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-824
Closed -$76K – 314
2018
Q3 		$76K Buy
824
+24
+3% +$2.85K 0.01% 307
2018
Q2 		$128K Buy
+800
New +$135K 0.01% 338

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Highland Capital Management (Tennessee)'s CLSD Position: Q4 2018 in Review

Highland Capital Management (Tennessee) sold out of Clearside Biomedical (CLSD) in Q4 2018, closing a stake of 824 shares — an estimated $76K sold.

Highland Capital Management (Tennessee) first reported a position in CLSD in Q2 2018 and held it in 2 quarters. The position peaked at $128K in Q2 2018. 69 funds tracked by Wall St. Rank hold CLSD as of Q4 2018.

  • Highland Capital Management (Tennessee) reported no remaining Clearside Biomedical position as of Q4 2018 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 824 Clearside Biomedical shares in Q4 2018, an estimated $76K.
  • Highland Capital Management (Tennessee) first reported a position in Clearside Biomedical in Q2 2018 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Clearside Biomedical position peaked at $128K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2018.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2018, filed 16 Jan 2019.